INS and Hyperglycemia: As discussed earlier, pathophysiology of NODAT and PTDM differs from that of T2DM in that post-transplant hyperglycemia is considered to be a result of impaired insulin secretion by pancreatic beta-cells instead of reduced insulin sensitivity.